CLINICAL AND PARACLINICAL FEATURES AND CAUSES OF FUNGAL PNEUMONIA IN PATIENTS TREATED AT HANOI MEDICAL UNIVERSITY

Nguyen Van Tan1, Pham Ngoc Minh1,2, Le Hoan1,2, Tran Khanh Chi1,2
1 Hanoi Medical University
2 Hanoi Medical University Hospital

Main Article Content

Abstract

Objective: Describe the clinical and paraclinical characteristics and evaluate the results of fungal etiology identification in patients with fungal pneumonia treated at Hanoi Medical University Hospital.


Methods: Conduct a cross-sectional descriptive study on 153 eligible patients with a diagnosis of fungal pneumonia and fungal etiology identification results who were treated as inpatients at Hanoi Medical University Hospital from January 2023 to January 2025.


Results: The average age was 65.75 ± 13.00, the age range from 60-75 accounted for 48.4%, male/female was 3/1. The main clinical symptoms included cough with phlegm (68%), shortness of breath (67.3%), fever (62.7%), decreased lung ventilation (68.6%), crackles (66%), and respiratory failure (65.4%). Common underlying diseases include diabetes (35.3%), COPD (33.3%), heart failure (16.3%), solid tumor (15%), and other chronic respiratory diseases (12.4%). Lung lesions on chest CT scans are mainly seen on both sides (86.3%), with consolidation (69.9%), bronchial wall thickening (64.4%), and ground glass (62.3%). Most patients have increased CRP (92.4%), increased PCT (98.4%), and increased neutrophil (80,4%). The most commonly isolated fungal pathogens are Candida spp. (80,4%) and Aspergillus spp. (18,3%).


Conclusion: The clinical and paraclinical characteristics of patients with fungal pneumonia are diverse. Diagnosis must combine both symptoms, risk factors in the patient and fungal test results to assess and predict treatment.

Article Details

References

[1] Bộ Y tế. Quyết định 3429/QĐ- BYT ngày 14/7/2021 về ban hành tài liệu chuyên môn “Hướng dẫn chẩn đoán và điều trị nhiễm nấm xâm lấn”. 2021.
[2] Romeo AM, et al. Fungal Pneumonia. Updated Sep 10, 2024. Medscape. https://emedicine.medscape.com/article/300341-overview. 2024.
[3] Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
[4] Denning DW, el al. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024 Jul. doi: 10.1016/S1473-3099(23)00692-8.
[5] Ngọc Minh Phạm và cộng sự. Tình hình nhiễm nấm trên bệnh nhân điều trị nội trú tại Bệnh viện Đại học Y Hà Nội năm 2022-2023. Tạp chí Y dược Huế. 2024. 101-107.
[6] Nhinh VT, Giáp VV. Đặc điểm lâm sàng, cận lâm sàng nấm phổi xâm lấn điều trị tại Trung tâm Hô hấp bệnh viện Bạch Mai. Tạp chí Y học Việt Nam. 2021. 506 (1).
[7] Thị Vân Anh Lê, Kim Thư Nguyễn. Đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị bệnh nhân viêm phổi do nấm tại Bệnh viện Nhiệt đới trung ương. Luận văn bác sĩ nội trú. Đại học Y Hà Nội. 2021.
[8] Rafat Z, Hashemi SJ, el al. Epidemiology, laboratory diagnosis and clinical aspects of fungal pulmonary infections in 384 patients hospitalized in pulmonary units in Guilan province, Iran. Iran J Microbiol. 2020 Aug; 12(4): 353-363. Doi: 10.18502/ijm.v12i4.3940.